Grace Therapeutics
GRCE
#9628
Rank
A$88.4 M
Marketcap
A$5.71
Share price
-0.49%
Change (1 day)
27.80%
Change (1 year)

Earnings for Grace Therapeutics (GRCE)

Earnings in 2025 (TTM): -A$14.8 Million

According to Grace Therapeutics's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -A$23.08 Million, an increase over its 2023 earnings that were of -A$68.21 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Grace Therapeutics from 2012 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$14.8 Million-35.89%
2024 -A$23.08 Million-66.16%
2023 -A$68.21 Million161.72%
2022 -A$26.06 Million60.58%
2021 -A$16.23 Million-462.11%
2020 A$4.48 M
2018 -A$35.31 Million
2015 -A$5.73 Million
2013 -A$13.92 Million49.55%
2012 -A$9.31 Million